PubRank

Diabetes Prevention Program Outcomes Study (DPPOS)

Clinical Trial ID NCT00038727

PubWeight™ 41.46‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00038727

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002 101.79
2 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009 15.00
3 Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet 2012 4.33
4 The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. Diabetes Care 2012 3.12
5 Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study. Diabetes Care 2012 1.78
6 The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up. J Clin Endocrinol Metab 2015 1.61
7 Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab 2016 1.57
8 Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study. Diabet Med 2013 1.51
9 Effectiveness and cost-effectiveness of diabetes prevention among adherent participants. Am J Manag Care 2013 1.18
10 Antidepressant medicine use and risk of developing diabetes during the diabetes prevention program and diabetes prevention program outcomes study. Diabetes Care 2010 1.15
11 HbA1c as a predictor of diabetes and as an outcome in the diabetes prevention program: a randomized clinical trial. Diabetes Care 2014 1.06
12 Impact of diagnosis of diabetes on health-related quality of life among high risk individuals: the Diabetes Prevention Program outcomes study. Qual Life Res 2013 0.96
13 Lifestyle and metformin interventions have a durable effect to lower CRP and tPA levels in the diabetes prevention program except in those who develop diabetes. Diabetes Care 2014 0.91
14 Regression from prediabetes to normal glucose regulation is associated with reduction in cardiovascular risk: results from the Diabetes Prevention Program outcomes study. Diabetes Care 2014 0.91
15 Common variants in genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1/2), adiponectin concentrations, and diabetes incidence in the Diabetes Prevention Program. Diabet Med 2012 0.91
16 Alcohol consumption and diabetes risk in the Diabetes Prevention Program. Am J Clin Nutr 2009 0.89
17 Long-term changes in dietary and food intake behaviour in the Diabetes Prevention Program Outcomes Study. Diabet Med 2014 0.88
18 Depression as a predictor of weight regain among successful weight losers in the diabetes prevention program. Diabetes Care 2012 0.87
19 Factors affecting the decline in incidence of diabetes in the Diabetes Prevention Program Outcomes Study (DPPOS). Diabetes 2014 0.86
20 Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention. Drugs 2015 0.86
21 Diabetes autoantibodies do not predict progression to diabetes in adults: the Diabetes Prevention Program. Diabet Med 2014 0.80
22 Repurposing old drugs to chemoprevention: the case of metformin. Semin Oncol 2015 0.80
23 Long-term prevalence and predictors of urinary incontinence among women in the Diabetes Prevention Program Outcomes Study. Int J Urol 2014 0.75
24 Depressive symptoms, antidepressant medication use, and new onset of diabetes in participants of the diabetes prevention program and the diabetes prevention program outcomes study. Psychosom Med 2015 0.75
Next 100